0.00Open0.00Pre Close0 Volume0 Open Interest92.00Strike Price0.00Turnover114.85%IV-14.66%PremiumDec 27, 2024Expiry Date11.76Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9106Delta0.0207Gamma6.66Leverage Ratio-0.1999Theta-0.0051Rho-6.06Eff Leverage0.0111Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet